Founded by Yale-trained vascular surgeon Dr. Roger Mason, Access for Life is developing a patented, sensor-equipped implantable device for vascular access during hemodialysis. The venture-backed medical-device start-up combines vascular and renal clinical expertise with engineering and business leadership, and its technology is currently undergoing in-vivo trials. Its development history includes a 2019 KidneyX Redesign Dialysis Phase 1 win and a 2022 short in-vivo trial at Mount Sinai.
EU Horizon 2020 research and innovation programme
Compliance program
Laminate Medical Technologies LtdFounded in 2012 by engineer Tammy Gilon and Dr. Eyal Orion, Laminate Medical Technologies develops medical devices aimed at making arteriovenous fistulas more usable for people receiving hemodialysis. Its flagship VasQ extravascular support device reinforces the fistula’s connection during maturation and is sold across the United States, Europe, Africa, Singapore and the United Kingdom. The company’s team spans Israel, Europe and the United States, with VasQ supported by CE marking and FDA clinical development.NEW YORK, NY
Medical Components, IncFounded in 1978 to make vascular access catheters for acute hemodialysis, Medical Components, Inc. now develops and manufactures devices used in dialysis and interventional medicine. The privately held company has grown from its early Tesio, Split Cath and Duo-Flow designs to more than 70 product lines and thousands of products, supported by in-house biomedical, mechanical and electrical engineers. Its manufacturing and quality systems are certified to ISO 13485 and MDSAP standards.HARLEYSVILLE, PA
VasocureVasocure is a novel therapeutics company developing peptide medicines for vascular disease, centered on Pedifin, its patented F11R blocker for neointimal disease and atherosclerosis. Founded by nephrologists and scientists involved in discovering the human F11 receptor, the company draws on more than two decades of research into vascular access failure in dialysis patients. Its 62-candidate pipeline spans nephrology, cardiology, and oncology, with Pedifin in preclinical and first-in-human studies.NEW YORK, NY
Spectrum VascularFounded in White Plains, New York, in 2023, Spectrum Vascular makes vascular-access and medication-management devices for clinical care. Its portfolio expanded through the acquisition of Cook Medical’s vascular-access business in 2023 and AngioDynamics’ PICC, midline, and tip-location products in 2024. The company combines established catheter technologies with newer tools such as its SV NAV+ real-time guidance platform, while emphasizing infection prevention in product design.WHITE PLAINS, NY